Cargando…

Use of the ROX index in the assessment of success of high-flow oxygen therapy in secondary hypoxemia to type 2 coronavirus()

Detalles Bibliográficos
Autores principales: González-Castro, A., Fajardo Campoverde, A., Roncalli Rocha, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. and SEMICYUC. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046062/
https://www.ncbi.nlm.nih.gov/pubmed/35527191
http://dx.doi.org/10.1016/j.medine.2022.04.010
_version_ 1784695442413453312
author González-Castro, A.
Fajardo Campoverde, A.
Roncalli Rocha, A.
author_facet González-Castro, A.
Fajardo Campoverde, A.
Roncalli Rocha, A.
author_sort González-Castro, A.
collection PubMed
description
format Online
Article
Text
id pubmed-9046062
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier España, S.L.U. and SEMICYUC.
record_format MEDLINE/PubMed
spelling pubmed-90460622022-04-28 Use of the ROX index in the assessment of success of high-flow oxygen therapy in secondary hypoxemia to type 2 coronavirus() González-Castro, A. Fajardo Campoverde, A. Roncalli Rocha, A. Med Intensiva (Engl Ed) Letter to the Editor Elsevier España, S.L.U. and SEMICYUC. 2022-07 2022-04-28 /pmc/articles/PMC9046062/ /pubmed/35527191 http://dx.doi.org/10.1016/j.medine.2022.04.010 Text en © 2021 Elsevier España, S.L.U. and SEMICYUC. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
González-Castro, A.
Fajardo Campoverde, A.
Roncalli Rocha, A.
Use of the ROX index in the assessment of success of high-flow oxygen therapy in secondary hypoxemia to type 2 coronavirus()
title Use of the ROX index in the assessment of success of high-flow oxygen therapy in secondary hypoxemia to type 2 coronavirus()
title_full Use of the ROX index in the assessment of success of high-flow oxygen therapy in secondary hypoxemia to type 2 coronavirus()
title_fullStr Use of the ROX index in the assessment of success of high-flow oxygen therapy in secondary hypoxemia to type 2 coronavirus()
title_full_unstemmed Use of the ROX index in the assessment of success of high-flow oxygen therapy in secondary hypoxemia to type 2 coronavirus()
title_short Use of the ROX index in the assessment of success of high-flow oxygen therapy in secondary hypoxemia to type 2 coronavirus()
title_sort use of the rox index in the assessment of success of high-flow oxygen therapy in secondary hypoxemia to type 2 coronavirus()
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046062/
https://www.ncbi.nlm.nih.gov/pubmed/35527191
http://dx.doi.org/10.1016/j.medine.2022.04.010
work_keys_str_mv AT gonzalezcastroa useoftheroxindexintheassessmentofsuccessofhighflowoxygentherapyinsecondaryhypoxemiatotype2coronavirus
AT fajardocampoverdea useoftheroxindexintheassessmentofsuccessofhighflowoxygentherapyinsecondaryhypoxemiatotype2coronavirus
AT roncallirochaa useoftheroxindexintheassessmentofsuccessofhighflowoxygentherapyinsecondaryhypoxemiatotype2coronavirus
AT useoftheroxindexintheassessmentofsuccessofhighflowoxygentherapyinsecondaryhypoxemiatotype2coronavirus